SD
Stephen D. Griffin
DELAYED 1 MONTH
Director, President and CEO
Anika Therapeutics, Inc.
Filings
2
Companies
1
Latest
Jun 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Anika Therapeutics, Inc.
Stephen D. Griffin
Director, President and CEO
Option Exercise
—
12,840 sh
Jun 5 8:05 PM
Jun 3, 2026
62
ANIK+51% IN
Anika Therapeutics, Inc.
Stephen D. Griffin
Director, President and CEO
Purchase
$149.9K
12,200 sh
Apr 30 9:22 PM
Apr 30, 2026